Amorsa Therapeutics Inc - Company Review
SummaryAmorsa Therapeutics Inc - Company Review
Summary
Amorsa Therapeutics Inc (Amorsa) is a neuropharmaceutical company that develops treatments for central nervous system diseases. The company discovers screening program to identify additional candidates and investigate other related indications such as post-traumatic stress disorder, bipolar depression and obsessive-compulsive disorder. Its product portfolio includes AMS-410 FA for the treatment of moderate and severe acute pain and AMS-520 ER for the treatment of moderate and severe chronic pain. The company’s proprietary technologies are used to provide properties to ketamine and ketamine analog-based formulations for use in the treatment of moderate-to-severe pain. Amorsa is headquartered in Littleton, Massachusetts, the US.
This comprehensive company report of Amorsa Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.